Insider Selling: Globe Life (NYSE:GL) CEO Sells 20,000 Shares of Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 20,000 shares of Globe Life stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Globe Life Trading Up 0.5%

Shares of NYSE:GL traded up $0.75 during trading hours on Tuesday, hitting $157.03. 166,192 shares of the company’s stock traded hands, compared to its average volume of 520,186. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $157.92. The business has a fifty day moving average price of $147.59 and a 200-day moving average price of $142.15. The firm has a market capitalization of $12.19 billion, a P/E ratio of 10.86 and a beta of 0.50. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter last year, the firm earned $3.07 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities analysts expect that Globe Life Inc. will post 15.57 earnings per share for the current year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is 9.13%.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Truist Financial boosted their target price on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Piper Sandler boosted their target price on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday. Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. JPMorgan Chase & Co. boosted their target price on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Morgan Stanley boosted their target price on Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, May 21st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $174.11.

Institutional Trading of Globe Life

Institutional investors and hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC bought a new position in Globe Life in the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC bought a new position in Globe Life in the fourth quarter worth approximately $30,000. MUFG Securities EMEA plc bought a new position in Globe Life in the second quarter worth approximately $31,000. Torren Management LLC bought a new position in Globe Life in the fourth quarter worth approximately $37,000. Finally, Root Financial Partners LLC bought a new position in Globe Life in the third quarter worth approximately $44,000. Institutional investors own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.